Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H LUND

Showing results (781-790 of 826) with videos related to

Pageof 83
Sort By:
European Journal of Heart Failure|October 19, 2017
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of CardiologyThomas M Gorter, Dirk J van Veldhuisen, Johann Bauersachs, et al.
Communications Biology|September 28, 2021
Genetic variants associated with platelet count are predictive of human disease and physiological markersEvgenia Mikaelsdottir, Gudmar Thorleifsson, Lilja Stefansdottir, et al.
Science (New York, N.Y.)|December 7, 2023
ROS-induced ribosome impairment underlies ZAKα-mediated metabolic decline in obesity and agingGoda Snieckute, Laura Ryder, Anna Constance Vind, et al.
ESC Heart Failure|July 23, 2022
Impact analysis of heart failure across European countries: an ESC-HFA position paperGiuseppe M C Rosano, Petar Seferovic, Gianluigi Savarese, et al.
JAMA|August 22, 2023
Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsHannes Helgason, Thjodbjorg Eiriksdottir, Magnus O Ulfarsson, et al.
Lancet (London, England)|June 24, 2026
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a studyLars H Lund, Arantxa Barandiarán Aizpurua, Entela Bollano, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 6, 2021
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of CardiologyGiuseppe Rosano, Ewa A Jankowska, Robin Ray, et al.
European Heart Journal|March 18, 2021
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCAndrew J S Coats, Stefan D Anker, Andreas Baumbach, et al.
Pageof 83

Showing results (781-790 of 826) with videos related to

Sort By:
Pageof 83
European Journal of Heart Failure|October 19, 2017
Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of CardiologyThomas M Gorter, Dirk J van Veldhuisen, Johann Bauersachs, et al.
Communications Biology|September 28, 2021
Genetic variants associated with platelet count are predictive of human disease and physiological markersEvgenia Mikaelsdottir, Gudmar Thorleifsson, Lilja Stefansdottir, et al.
Science (New York, N.Y.)|December 7, 2023
ROS-induced ribosome impairment underlies ZAKα-mediated metabolic decline in obesity and agingGoda Snieckute, Laura Ryder, Anna Constance Vind, et al.
ESC Heart Failure|July 23, 2022
Impact analysis of heart failure across European countries: an ESC-HFA position paperGiuseppe M C Rosano, Petar Seferovic, Gianluigi Savarese, et al.
JAMA|August 22, 2023
Evaluation of Large-Scale Proteomics for Prediction of Cardiovascular EventsHannes Helgason, Thjodbjorg Eiriksdottir, Magnus O Ulfarsson, et al.
Lancet (London, England)|June 24, 2026
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a studyLars H Lund, Arantxa Barandiarán Aizpurua, Entela Bollano, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|October 17, 2020
Heart Failure Association of the European Society of Cardiology update on sodium-glucose co-transporter 2 inhibitors in heart failurePetar M Seferović, Gabriele Fragasso, Mark Petrie, et al.
European Journal of Heart Failure|October 6, 2021
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of CardiologyGiuseppe Rosano, Ewa A Jankowska, Robin Ray, et al.
European Heart Journal|March 18, 2021
The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESCAndrew J S Coats, Stefan D Anker, Andreas Baumbach, et al.
Pageof 83